Acute and chronic inflammatory pain models have been used routinely by the pharmaceutical industry to provide information that helps to guide strategic decision-making around the mechanism of action and efficacy of molecules targeting inflammatory pain as well as providing robust pharmacodynamic end-points.

Examples of the models we offer include:

Examples of end points:


pain1This list is not exhaustive, we are always developing new areas of discovery within our preclinical field of expertise. If there is something particular that is not listed here please do contact us.